ROH detection system
By selecting 31 highly polymorphic STR sites and specific primers on chromosome 6, combined with second-generation sequencing technology, the problems of low efficiency and high cost of detection of ROH and single parent disomes in the existing technology are solved, and high efficiency is achieved. Accurate prenatal screening and disease diagnosis.
Patent Information
- Application Number
- CN202310610122.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-26
- Publication Date
- 2024-11-26
AI Technical Summary
Existing technologies are difficult to effectively detect and diagnose ROH and single parental disomes in chromosomal homozygous regions, resulting in inefficient and costly prenatal screening and related diseases diagnosis.
A detection system based on STR second-generation sequencing was developed. Using 31 highly polymorphic STR sites and specific primers on chromosome 6, ROH and single parent disomes were identified through PCR and sequencing technology to determine the single parent disomes. Parental origin.
It improves the efficiency and accuracy of ROH and single parent dual-body detection, reduces the detection cost, is suitable for the detection of tissues such as embryos, amniotic fluid and blood, simplifies the operation process, and is suitable for prenatal screening and genetic diagnosis.
Smart Images

Figure BDA0004252379980000111 
Figure BDA0004252379980000112 
Figure BDA0004252379980000113
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biological gene detection, and in particular relates to a ROH and uniparental disomy detection system. Background Art
[0002] Runs of homozygosity (ROH) refers to the genomic region that shows loss of heterozygosity of alleles. If there is only one type of genome (from the father or mother) in the region due to chromosome loss and duplication, meiotic errors, and consanguinity, the region is a genomic homozygous ROH.
[0003] The most representative type of ROH is uniparental disomy. Uniparental disomy (UPD) refers to the replacement of a chromosome segment from one parent by the homologous segment from the other parent, or the two homologous chromosomes of an individual come from the same parent. According to the source, UPD can be divided into: uniparental isodisomy (isoUPD) of the same chromosome from the same parent, uniparental heterodiploidy (heterodisomy, hetUPD) of two homologous chromosomes from the same parent, mixed uniparental disomy (mixUPD) with both uniparental isodisomy and uniparental heterodiploidy, and segmental uniparental disomy (segUPD) with partial replacement of chromosome segments.
[0004] The occurrence of chromosomal UPD in live births is about 1:3500, but some types of UPD patients do not have any abnormal clinical phenotypes, and some types of UPD even affect the growth and development of the embryo and lead to early miscarriage, so the probability of chromosomal UPD may be higher than 1 / 3500. UPD can be associated with disease in many ways, including imprinting disorders, low-level mosaicism of original aneuploidy, or masking of recessive diseases caused by pathogenic variants carried by only one parent. Human chromosome 6 contains imprinted genes. Current reports show that imprinting disorders of genes PLAGL1 (genomic location: GRCh37.p13 chr6:144261437-144385736, 6q24.2) and HYMAI (genomic location: GRCh37.p13 chr6:144326053-144329396, 6q24.2) can cause transient neonatal diabetes mellitus (TNDM1, OMIM#601410). Overexpression of PLAGL1 or HYMAI through uniparental disomy, chromosome duplication or imprinting relaxation can cause TNDM1.
[0005] Short tandem repeats (STR) are usually a DNA repeat sequence consisting of 1 to 6 base units in the genome. Since the number of core unit repeats is highly variable between individuals and the number is abundant, it constitutes the genetic polymorphism of the STR locus. It is generally believed that there is an STR locus every 15kb of the human genome on average, accounting for about 7% of the human genome sequence, with a fragment size of 70 to 500bp, and it is co-dominantly inherited according to Mendel's law. However, uniparental disomy and chromosome deletion mutations cannot be distinguished by STR typing alone.
[0006] Therefore, the development of STR typing for UPD detection is of great significance for prenatal screening and diagnosis of related diseases. Summary of the invention
[0007] In order to solve the above problems, the present invention develops a system for detecting ROH and uniparental disomy in homozygous chromosome regions based on STR second-generation sequencing.
[0008] The present invention first provides an STR combination or STR marker, comprising 31 STR loci located on chromosome 6 and 1 kb upstream and 1 kb downstream of each locus, or fragments thereof, wherein the STR loci include: D6S477, D6S1279, D6S2439, D6S1960, D6S1053, D6S1275, D6S1052, D6S1043, D6S474, D6S1040, D6S2409, D6S1009, D6S970, D6S971, D6G1583 3. D6S2436, D6S1277, STR_1278631, STR_1279799, STR_1280227, STR_1280328, STR_1281116, STR_1281316, STR _1281395, STR_1281508, STR_1281666, STR_1282563, STR_1282613, STR_1282956, STR_1283352, STR_1283624.
[0009] In one or more embodiments, the STR panel further comprises one or more STR loci as internal references and 1 kb upstream and 1 kb downstream of each locus, or fragments thereof.
[0010] The present invention also provides a reagent for detecting the STR combination described in any embodiment of the present invention in a sample.
[0011] In one or more embodiments, the reagent is a primer molecule that hybridizes to a sequence of the STR combination, and the primer molecule is capable of amplifying the STR locus.
[0012] In one or more embodiments, the primers include an upstream primer and a downstream primer. The upstream primer includes a universal sequence at the 5' end and a specific sequence for the STR site at the 3' end, and the 5' end of the upstream primer is complementary to a partial sequence at the 3' end of the adapter primer F. The downstream primer includes a universal sequence at the 5' end and a specific sequence for the STR site at the 3' end, and the 5' end of the downstream primer is complementary to a partial sequence at the 3' end of the adapter primer R.
[0013] In one or more embodiments, the specific sequence for the STR locus in the upstream primer comprises a sequence as shown in one or more or all of SEQ ID NOs: 6-36.
[0014] In one or more embodiments, the specific sequence for the STR locus in the downstream primer comprises a sequence as shown in one or more or all of SEQ ID NOs: 42-72.
[0015] In one or more embodiments, the primer comprises
[0016] (1) one or more or all of SEQ ID NOs: 78-108, and / or
[0017] (2) one or more or all of SEQ ID NOs: 114-144.
[0018] In one or more embodiments, the sample is from a mammal, preferably a human.
[0019] In one or more embodiments, the sample is amniotic fluid, embryonic or body fluid.
[0020] The present invention also provides the use of a reagent for detecting the STR combination described in any embodiment of the present invention in preparing a diagnostic kit, wherein the kit is used for identifying ROH, identifying uniparental disomy variation, determining the parental origin of uniparental disomy, and performing prenatal screening or diagnosis.
[0021] In one or more embodiments, the agent is an agent as described in any of the embodiments herein.
[0022] In one or more embodiments, the identifying of ROH, identifying of uniparental disomy variation, and determining the parental source of uniparental disomy are respectively identifying whether ROH exists on chromosome 6, identifying of uniparental disomy variation on chromosome 6, and determining the parental source of uniparental disomy on chromosome 6.
[0023] The present invention also provides a method for identifying a homozygous region ROH of a chromosome, identifying a uniparental disomy variation, and determining the parental source of a uniparental disomy, comprising the steps of:
[0024] (1) detecting the sequence of the STR combination, wherein the STR combination is preferably as described in any embodiment of the present invention,
[0025] (2) Based on the test results of the STR combination, determine the STR allele typing, the relative sequencing depth difference of each STR, and verify the STR continuous interval, so as to identify whether the chromosome contains ROH.
[0026] Optional (3) judging uniparental disomy or uniparental disomy parental origin according to STR allele typing of the pedigree sample and whether the chromosome contains ROH. The pedigree sample at least includes an offspring sample and at least one parent sample.
[0027] In one or more embodiments, step (1) comprises constructing a library comprising the STR combination and sequencing it.
[0028] In one or more embodiments, step (1) includes the steps of: (1.1) genomic DNA extraction, and (1.2) PCR using primers capable of amplifying the STR combination to obtain a library containing the STR combination. Step (1) also includes: (1.3) PCR using sequencing adapter primers to obtain a sequencing library containing the STR combination.
[0029] In one or more embodiments, in step (2), when the average value of the relative sequencing depth difference is 0.7 to 1.4, and the STR typing results in the continuous interval are: there are no 3 or more STRs of one type (homozygous alleles, gene frequency is about 1), then the continuous interval excludes ROH; when the relative value of STR sequencing depth is 0.7 to 1.4 (preferably 1.0), and the STR typing results in the continuous interval are: there are 3 or more STRs of one type (homozygous alleles, gene frequency is about 1), then the STR homozygous gene range has ROH.
[0030] In one or more embodiments, in step (3), the parental origin of the offspring uniparental disomy and uniparental disomy is determined based on the STR typing results. When the STRs in the continuous interval are all of the same typing (i.e., homozygous genes), and the average value of the relative sequencing depth difference in the continuous interval is 0.7 to 1.4 (preferably 1.0), the continuous interval is uniparental disomy. When the STR typing in the continuous interval is the same as that of a parent, the uniparental disomy originates from the parent.
[0031] Another aspect of the present invention provides a device for identifying homozygous chromosome regions ROH, identifying uniparental disomy variation, and determining the parental origin of uniparental disomy, the device comprising a memory, a processor, and a computer program stored in the memory and executable on the processor, wherein the processor implements the following steps when executing the program:
[0032] (1) obtaining the sequence of the STR combination in the sample of the subject, wherein the STR combination is preferably as described in any embodiment of the present invention,
[0033] (2) Based on the test results of the STR combination, determine the STR allele typing, the relative value of each STR sequencing depth, and verify the STR continuous interval, so as to identify whether the chromosome contains ROH.
[0034] Optional (3) judging uniparental disomy or uniparental disomy parental origin according to STR allele typing of the pedigree sample and whether the chromosome contains ROH. The pedigree sample at least includes an offspring sample and at least one parent sample.
[0035] In one or more embodiments, step (1) comprises constructing a library comprising the STR combination and sequencing it.
[0036] In one or more embodiments, step (1) includes the steps of: (1.1) genomic DNA extraction, and (1.2) PCR using primers capable of amplifying the STR combination to obtain a library containing the STR combination. Step (1) also includes: (1.3) PCR using sequencing adapter primers to obtain a sequencing library containing the STR combination.
[0037] In one or more embodiments, in step (2), when the average value of the relative sequencing depth difference is 0.7 to 1.4, and the STR typing results in the continuous interval are: there are no 3 or more STRs of one type (homozygous alleles, gene frequency is about 1), then the continuous interval excludes ROH; when the relative value of STR sequencing depth is 0.7 to 1.4 (preferably 1.0), and the STR typing results in the continuous interval are: there are 3 or more STRs of one type (homozygous alleles, gene frequency is about 1), then the STR homozygous gene range has ROH.
[0038] In one or more embodiments, in step (3), the parental origin of the offspring uniparental disomy and uniparental disomy is determined based on the STR typing results. When the STRs in the continuous interval are all of the same typing (i.e., homozygous genes), and the average value of the relative sequencing depth difference in the continuous interval is 0.7 to 1.4 (preferably 1.0), the continuous interval is uniparental disomy. When the STR typing in the continuous interval is the same as that of a parent, the uniparental disomy originates from the parent.
[0039] Advantages of the present invention:
[0040] The STR detection system involved in the present invention, its STR site selection and primer design, and sequencing data analysis process are all relatively good choices after experimental comparison.
[0041] The STR detection system involved in the present invention is suitable for detecting ROH and uniparental disomy in the homozygous region of chromosome 6 in tissues such as embryos, amniotic fluid and blood, and can exclude the quantitative abnormalities of euploidy and large fragments of chromosome 6.
[0042] The present invention solves the problems of low throughput and high cost in the detection of ROH and uniparental disomy in homozygous chromosome regions in the past, and has fast detection speed and simple operation, and can be used for prenatal screening and genetic diagnosis. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] Figure 1 .F0002S STR test results.
[0044] Figure 2 .F0004S STR test results.
[0045] Figure 3 .F0000S STR test results.
[0046] Figure 4 .F0001S STR test results. DETAILED DESCRIPTION
[0047] The present invention develops the application of STR typing in UPD detection through second-generation sequencing, which is of great significance for prenatal screening and diagnosis of related diseases.
[0048] The next generation sequencing (NGS) technology detects STR and can simultaneously determine the DNA sequence of multiple loci, obtain the variation information of the number of sub-repeated sequences contained in the repeat region and flanking region of each STR site, and realize the typing and sequencing depth statistics of each STR site. In addition, STR amplification based on the NGS platform can identify different samples by connecting specific tag sequences at both ends of the target sequence, which can accommodate up to dozens or hundreds of samples for simultaneous testing, greatly improving the detection efficiency.
[0049] At present, a relatively complete genetic marker map has been drawn for the human genome, but by analyzing the 1000 Genomes, nearly 90% of the STR variation information was obtained (Willems T et al. 2014). After long-term research and exploration, the inventors screened highly polymorphic sites for improving UPD detection, with low detection costs and fast detection speed. In different regions of chromosome 6, especially the 6q24.2 region, highly polymorphic STR sites were screened, and sequenced simultaneously using NGS technology, and the typing and sequencing depth statistics of STR sites were analyzed to determine the uniparental disomy variation of the sample.
[0050] Specifically, the present invention provides a system for detecting homozygous region ROH and uniparental disomy of human chromosome 6 based on STR second-generation sequencing, the system comprising 31 highly polymorphic STR loci located on chromosome 6, and primers for constructing second-generation sequencing libraries. The present invention also provides an analysis process for detecting homozygous region ROH and uniparental disomy variation of chromosome 6 using STR second-generation sequencing data. The present invention is used for prenatal screening of fetuses and diagnosis of whether there is homozygous region ROH on chromosome 6 of patients, and judging the parental origin of uniparental disomy and uniparental disomy of chromosome 6 through family samples.
[0051] The present invention first provides an STR combination or STR marker, comprising 31 STR loci on chromosome 6 and 1 kb upstream and 1 kb downstream of each locus, or fragments thereof. The STR loci include 17 STR loci selected from a genetic marker map: D6S477, D6S1279, D6S2439, D6S1960, D6S1053, D6S1275, D6S1052, D6S1043, D6S474, D6S1040, D6S2409, D6S1009, D6S970, D6S971, D6G15833, D6S2436, D6S1277, which are scattered on chromosome 6, and 17 STR loci selected from a WebSTR database. 14 STR loci STR_1278631, STR_1279799, STR_1280227, STR_1280328, STR_1281116, STR_1281316, STR_1281395, STR_1281508, STR_1281666, STR_1282563, STR_1282613, STR_1282956, STR_1283352, STR_1283624, are scattered in the 6q24.2 region. In one or more embodiments, the fragments are each STR locus.
[0052] In addition, the STR combination of the present invention further comprises one or more (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more) STR loci as internal references. Such STR loci may be located on other chromosomes, such as D1S1162, D1S551, D2S1379, D2S2968, and D3S2454 located on other chromosomes.
[0053] The inventors have found that by detecting the above-mentioned STR in genomic DNA and analyzing its typing and sequencing depth statistics, it is possible to determine the uniparental disomy variation of the sample. Therefore, the present invention also provides reagents for detecting the STR combination. Any method in the art that can be used to determine nucleic acid sequences and the reagents required therefor can be used in the present invention to detect STR, such as nucleic acid hybridization, PCR, DNA sequencing, fluorescence quantification, and mass spectrometry. These methods and the universal reagents required therefor (such as buffers) are within the knowledge of those skilled in the art. In one or more embodiments, the detection includes detecting any chain at a gene or site. DNA sequencing includes first, second, or third generation sequencing technologies. In a specific embodiment, DNA sequencing is a second generation sequencing technology based on bridge PCR.
[0054] The reagents used in the above-mentioned methods for detecting STR are well known in the art. The present invention also provides the use of these reagents in preparing a diagnostic kit for identifying ROH, identifying uniparental disomy variation, determining the parental origin of uniparental disomy, and performing prenatal screening or diagnosis.
[0055] In the detection method involving DNA amplification, the reagent for detecting STR includes primers for amplifying the STR site sequence of the STR combination. The "primer" described herein refers to a nucleic acid molecule with a specific nucleotide sequence that guides the synthesis at the initiation of nucleotide polymerization. The primer is usually at least 9 bp. The primer sequence can be specific or non-specific for the STR sequence. Usually, the primer is designed to amplify a product length of 1-2000 bp, 10-1000 bp, 30-900 bp, 40-800 bp, 50-700 bp, or at least 150 bp, at least 140 bp, at least 130 bp, at least 120 bp.
[0056] Primers generally include an upstream primer and a downstream primer. In some embodiments herein, the upstream primer in the primer for detecting STR includes a universal sequence at the 5' end and a specific sequence for the STR site at the 3' end, wherein the 5' end of the upstream primer is complementary to a partial sequence at the 3' end of the adapter primer F; and the downstream primer includes a universal sequence at the 5' end and a specific sequence for the STR site at the 3' end, wherein the 5' end of the downstream primer is complementary to a partial sequence at the 3' end of the adapter primer R. Adapter primers are primers used for amplification in sequencing, and their sequences are provided by sequencing companies or can be obtained by those skilled in the art based on product information. Exemplarily, adapter primers F and R are adapter primers F and R of the Illumina sequencing platform.
[0057] In some embodiments, the specific sequence for the STR locus in the upstream primer comprises a sequence as shown in one or more or all of SEQ ID NOs: 6-36, and the specific sequence for the STR locus in the downstream primer comprises a sequence as shown in one or more or all of SEQ ID NOs: 42-72. In addition, the specific sequence for the STR locus in the upstream primer also includes a sequence as shown in one or more or all of SEQ ID NOs: 1-5 for an internal reference, and the specific sequence for the STR locus in the downstream primer also includes a sequence as shown in one or more or all of SEQ ID NOs: 37-41 for an internal reference.
[0058] In a more specific embodiment, the primer comprises: one or more or all of SEQ ID NOs: 78-108, and / or one or more or all of SEQ ID NOs: 114-144. In addition, the primer may also comprise one or more or all of SEQ ID NOs: 73-77 for internal reference, and / or one or more or all of SEQ ID NOs: 109-113.
[0059] The upstream primer and the downstream primer of the present invention can be mixed (eg, mixed in equal proportions) for multiplex PCR, and the working concentration thereof is 0.001-1 μM, preferably 0.01-0.1 μM, for example 0.05 μM.
[0060] The reagents for detecting STR may also include probes that hybridize with the sequence to be detected. Usually, the 5' end of the sequence of the probe is labeled with a fluorescent reporter group, and the 3' end is labeled with a quencher group. The "hybridization" described herein mainly refers to the pairing of nucleic acid sequences under stringent conditions. Exemplary stringent conditions are hybridization and washing of the membrane at 65°C in a solution of 0.1×SSPE (or 0.1×SSC), 0.1% SDS.
[0061] The DNA contained in the biological sample can be cellular DNA or circulating free DNA (cfDNA). Separation and purification of DNA from a biological sample can be implemented using various methods known in the art, including the use of commercially available kits. For example, DNA is isolated from cells and tissues by: cleavage of raw materials under highly denaturing and reducing conditions, partial use of protein degrading enzymes, purification of nucleic acid components obtained by phenol / chloroform extraction processes, and recovery of nucleic acids from the aqueous phase by dialysis or ethanol precipitation.
[0062] The term "sample" as used herein refers to a biological composition containing DNA obtained or derived from a target individual, including but not limited to cells, tissues, organs and / or biological fluids of an individual obtained by any method known to those skilled in the art. In some embodiments, the biological sample is selected from the group consisting of histological sections, tissue biopsies, paraffin-embedded tissues, body fluids, colon effluents, surgical resection specimens, embryos, isolated blood cells, cells isolated from blood, and any combination thereof. In some embodiments, the body fluid is selected from the group consisting of amniotic fluid, whole blood, serum, plasma, urine, mucus, saliva, peritoneal fluid, pleural fluid, pleural effusion, synovial fluid, cerebrospinal fluid, thoracentesis fluid, peritoneal effusion, and any combination thereof. In some embodiments, the colon effluent is selected from the group consisting of fecal samples and enema washing samples. In some embodiments, the biological sample is obtained from an embryo, amniotic fluid, or whole blood.
[0063] The term "subject" or "individual" as used herein includes humans and non-human animals. Non-human animals include all vertebrates, such as mammals and non-mammals. In some embodiments, the subject is a human.
[0064] In addition to the primers, probes, and nucleic acid molecules, the kit also includes other reagents required for detecting nucleic acid sequences. Exemplary other reagents include one or more of the following: PCR buffer, polymerase, dNTP, Mg2+, restriction endonuclease, enzyme digestion buffer, fluorescent dye, fluorescence quencher, fluorescent reporter, exonuclease, alkaline phosphatase, internal standard, and control. The kit may also include a container suitable for storing biological samples and / or instructions for use. The kit may also include reagents for obtaining DNA from samples.
[0065] The present invention further provides a method for identifying a homozygous region ROH of a chromosome, identifying a uniparental disomy variation, and determining the parental source of a uniparental disomy, comprising the steps of:
[0066] (1) Detect the sequence of STR combination,
[0067] (2) According to the test results of STR combination, determine the STR allele typing, the relative value of each STR sequencing depth and verify the STR continuous interval, so as to determine whether the chromosome contains ROH.
[0068] (3) Determine uniparental disomy or uniparental disomy parental origin based on STR allele typing of the pedigree sample and whether the chromosome contains ROH. The pedigree sample at least includes an offspring sample and at least one parent sample.
[0069] In a specific embodiment, the STR combination includes STR loci on chromosome 6, and the identifying of ROH, identifying uniparental disomy variation, and determining the parental source of uniparental disomy respectively include identifying whether ROH exists on chromosome 6, identifying uniparental disomy variation on chromosome 6, and determining the parental source of uniparental disomy on chromosome 6.
[0070] In one or more embodiments, step (1) includes constructing a library comprising the STR combination and sequencing. In the present invention, the sequencing (e.g., next-generation sequencing) library construction method can use publicly available sequencing library preparation reagents and processes, which are within the knowledge of those skilled in the art. In a specific embodiment, the above step (1) includes the steps of:
[0071] (1.1) Genomic DNA extraction, and
[0072] (1.2) Perform PCR using primers that can amplify the STR combination to obtain a library containing the STR combination. The PCR product is usually purified.
[0073] In addition, in a specific sequencing embodiment, step (1) further comprises: (1.3) performing PCR on the library using a sequencing adapter primer to obtain a sequencing library comprising the STR combination. The PCR product is usually purified.
[0074] In a specific embodiment, an Illumina sequencing platform is used, and thus the sequencing adapters are Illumina sequencing platform adapters.
[0075] The method of the present invention also includes sequencing data analysis after obtaining the sequencing results, which is mainly divided into STR allele typing, statistics of relative values of each STR sequencing depth and verification of STR continuous intervals, so as to comprehensively judge the variation of chromosome 6 of the sample. In step (2), when the average value of the relative sequencing depth difference is 0.7-1.4, and the STR typing result in the continuous interval is: there are no continuous 3 or more STRs of one type (allele homozygous, gene frequency is about 1), then the continuous interval excludes ROH; when the STR sequencing depth relative value is 0.7-1.4 (preferably 1.0), and the STR typing result in the continuous interval is: there are continuous 3 or more STRs of one type (allele homozygous, gene frequency is about 1), then the STR homozygous gene range has ROH.
[0076] In step (3), the parental origin of the offspring uniparental disomy and uniparental disomy is determined based on the STR typing results. When the STRs in the continuous interval are all of the same type (i.e., homozygous genes), and the average value of the relative sequencing depth difference in the continuous interval is 0.7 to 1.4 (preferably 1.0), the continuous interval is uniparental disomy. When the STR typing in the continuous interval is the same as that of a parent, the uniparental disomy originates from the parent.
[0077] A variety of analysis methods known in the art can be used to determine STR allele typing, calculate relative values of each STR sequencing depth, and verify STR continuous intervals. The specific analysis method can be selected by those skilled in the art. The present invention exemplarily shows the following analysis process.
[0078] 1) STR allele typing
[0079] STR allele typing is used to identify each STR as a heterozygous, homozygous, tri-allelic heterozygous gene or other typing status, and to calculate the proportion of the sequencing depth of different alleles to the total depth of the site.
[0080] Use MISA software to process the data, including the following steps:
[0081] 1. Extract reads based on upstream and downstream specific primers of STR loci.
[0082] 2. Based on the quality of reads, remove reads with a Q-score higher than 20 and a base ratio lower than 80%.
[0083] 3. Convert fastq to fasta sequence.
[0084] 4. Run MISA to identify simple sequence repeats (SSRs). The identified SSRs are required to have 2, 3, 4 and 5 base sequences repeated more than 4 times, and the maximum distance between two SSRs should not exceed 50 bases.
[0085] 5. For each STR locus of each sample, calculate the proportion of typing results of each repeat number to the total depth of the locus, remove SSR typing results with a proportion of less than 10%, and give the final typing.
[0086] 2) Count the relative values of each STR sequencing depth
[0087] The relative value statistics of STR sequencing depth are used to verify the continuous interval of sample STR. The calculation process includes the following steps:
[0088] 1. Calculate the depth ratio of the test site of a single sample:
[0089]
[0090] 2. Calculate the mean of the internal reference sites for a single sample:
[0091]
[0092] 3. Calculate the mean of the depth ratio of the tested sites of negative samples:
[0093]
[0094] 4. Calculate the mean of the internal reference sites of negative samples:
[0095]
[0096] 5. Calculate the relative sequencing depth difference and its average value between the tested sample and the negative sample
[0097]
[0098] Calculate STR based on the number of loci i Average: STR i The sum is divided by the number of sites n (i.e., the average relative sequencing depth difference).
[0099] 3) Verify STR continuous interval
[0100] The relative sequencing depth differences of STRs were divided into segments using the ring binary segmentation algorithm (CBS). The significance of the difference between the groups (p<0.05) was determined by randomly permuting the data within the divided fragments 1000 times, and the fragments were further divided to determine the fragment intervals with significant differences in sequencing depth (p<0.01). The intervals with different sequencing depths were corrected in combination with the STR typing results, and the multiples of the STR typing with the most occurrences in each interval were counted. If the multiples of STR typing between the intervals with different depths were inconsistent, the depth differences of the intervals were compared after the expansion boundary. If there was a significant difference in depth between the expansion and the expansion (p<0.05), the depth differences of the intervals were compared after the reverse reduction boundary. If there was a significant difference in depth between the reduction and the reduction (p<0.05), the breakpoints were not corrected, otherwise the corrected intervals were accepted to give the final STR continuous interval.
[0101] 4) Data analysis
[0102] Based on the STR typing results, STR sequencing depth relative value and STR continuous interval obtained in the above process, the following analysis was performed.
[0103] When the average value of the relative sequencing depth difference of the STR continuous interval is close to 0.7-1.4, the chromosome sequence copy number of the interval is 2, indicating that there is no deletion or duplication in the STR continuous interval; if the STR typing results in the continuous interval show that there are no consecutive 3 or more STRs of the same type (allele homozygous, gene frequency is about 1), ROH is excluded in this area; if the STR typing results in the continuous interval show that there are consecutive 3 or more STRs of the same type (allele homozygous, gene frequency is about 1), ROH is highly suspected to exist in the STR homozygous gene range.
[0104] When the average value of the relative sequencing depth difference of the STR continuous interval is less than or equal to 0.7 or is 0, the chromosome sequence copy number of the interval is 1 or 0, indicating that there is a deletion in the STR continuous interval, and the STR typing results in the continuous interval are all STR one typing (allele homozygous, gene frequency is about 1) or STR no data (gene frequency is about 0).
[0105] When the average value of the relative sequencing depth difference of the STR continuous interval is greater than or equal to 1.4, the chromosome sequence copy number of the interval is 3 or an integer greater than 3, indicating that the STR continuous interval is repeated. When the STR typing results in the continuous interval show three typings (three alleles heterozygous, gene frequency is about 1:1:1), or two STR typings (allele heterozygous, gene frequency is about 1:2), or one STR typing (allele homozygous, gene frequency is about 1), the chromosome sequence copy number of the interval is 3.
[0106] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are calculated by weight.
[0107] Example
[0108] The following is the test of 6 samples with known mutations using the present invention. The embryo sample F0002S has a chromosome 6 segment deletion, the embryo sample F0004S has a chromosome 6 duplication, and the amniotic fluid sample F0000S has a chromosome 6 segment heterozygous deletion; the F0001 family paternal F0001F and maternal F0001M are normal, and the embryo sample F0001S has a paternal uniparental chromosome diploidy. The specific implementation of the above samples is as follows:
[0109] 1. DNA Extraction
[0110] DNA was extracted using the Tiangen Genome Extraction Kit, and the operation steps were carried out according to the instructions. After DNA extraction, Qubit was used for quantification.
[0111] 2. First round of STR locus multiplex amplification
[0112] 2.1 PCR system
[0113] The upstream primers and downstream primers of the 36 STR locus sequences in Table 1 below were mixed in equal proportions to form a 1 μM mixture (multiple panels) with a working concentration of 0.05 μM.
[0114] Table 1 STR locus amplification primers
[0115]
[0116]
[0117]
[0118] After oscillating and mixing each reaction reagent, prepare the PCR reaction mixture according to the volume ratio in the table below, divide it into reaction tubes, and finally add 50 to 200 ng of DNA template to each tube. After a brief centrifugation, proceed to the next step.
[0119] Amplification reaction system
[0120] 2xKAPA Mμltipiex PCR Mix 10μl Multiple Panel 1μl DNA template xμl water To 20μl
[0121] 2.2 PCR procedure
[0122] Place the PCR reaction tube on the thermal amplification instrument, design and run the following program: Step 1: denaturation at 96°C for 3 minutes, step 2: denaturation at 96°C for 30 seconds, step 3: extension at 60°C for 4 minutes, repeat steps 2 to 3 22 times, and finally extend at 72°C for 5 minutes. After the run, store the product in a refrigerator at 4°C.
[0123] 3. Multiplex PCR Product Purification
[0124] 1) Add 0.6 times volume of magnetic beads to the reaction system (12 μl for 20 μl system), mix thoroughly, and let stand at room temperature for 5 minutes.
[0125] 2) Centrifuge the reaction tube briefly and place it on a magnetic rack to adsorb the magnetic beads for 2 minutes. When the solution is clear, use a pipette to carefully transfer all the supernatant to a new reaction tube.
[0126] 3) Add 0.9 times the volume of magnetic beads to the supernatant (18 μl for a 20 μl system), mix thoroughly, and let stand at room temperature for 5 minutes.
[0127] 4) Centrifuge the reaction tube briefly and place it on a magnetic rack to adsorb the magnetic beads for 2 minutes. Wait until the solution is clear and carefully discard all the supernatant with a pipette.
[0128] 5) Add 40 μl BW13, mix thoroughly, and let stand at room temperature for 5 minutes.
[0129] 6) Centrifuge the reaction tube briefly and place it on a magnetic rack to adsorb the magnetic beads for 2 minutes. Wait until the solution is clear and carefully discard all the supernatant with a pipette.
[0130] 7) Add 150 μl of 80% ethanol (do not disperse the magnetic beads), use the magnetic rack to repeatedly adsorb the magnetic beads on two different sides to fully suspend the magnetic beads for washing, and carefully aspirate and discard all the supernatant with a pipette.
[0131] 8) Let stand at room temperature until the ethanol is completely evaporated, add 8 μl of nuclease-free water, mix thoroughly, and proceed to the next step.
[0132] 4. Second round of sequencing adapter ligation
[0133] 4.1 PCR system
[0134] The Illumina sequencing platform adapter primers F and R (Index Primer F / R) were diluted to 10 μM, respectively, and their working concentration was 0.5 μM. Among them, the adapter primer F sequence is: AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATC, and the adapter primer R sequence is: CAAGCAGAAGACGGCATACGAGATNNNNNNGTGACTGGAGTTCCTTGGCACCCGAGAATTC, NNNNNN is the index sequence, which is used to split the data of each library in the offline data.
[0135] After oscillating and mixing the reaction reagents, prepare the PCR reaction mixture according to the volume ratio in the table below, dispense into reaction tubes, and add the products after the first round of PCR fragment screening.
[0136] Amplification reaction system
[0137] 2xKAPA Mμltipiex PCR Mix 10μl Index Primer F 1μl Index Primer R 1μl Products after the first round of PCR fragment screening 8μl total 20μl
[0138] 4.2 PCR procedure
[0139] Place the PCR reaction tube on the thermal amplification instrument, design and run the following program: Step 1: denaturation at 96°C for 3 minutes, Step 2: denaturation at 96°C for 30 seconds, Step 3: annealing at 58°C for 30 seconds, Step 4: extension at 72°C for 30 seconds, repeat steps 2 to 4 10 times, and finally extend at 72°C for 2 minutes. After the run, if the next step is not performed, store the product in a refrigerator at -20°C.
[0140] 5. Library quality control
[0141] 1 μl of each sample was taken for 2% agarose gel electrophoresis. If the target band of the library was around 280 bp, no large fragments remained, and no primer dimers were present, the library quality inspection was qualified and the library was purified.
[0142] 6. Library Purification
[0143] 1) Add 1.0 times volume of magnetic beads (9 μl magnetic beads) to the reaction system, mix thoroughly, and let stand at room temperature for 5 minutes;
[0144] 2) Centrifuge the reaction tube briefly and place it on a magnetic rack to adsorb the magnetic beads for 2 minutes. When the solution is clear, carefully aspirate and discard all the supernatant with a pipette;
[0145] 3) Add 40 μl BW10, mix thoroughly, and let stand at room temperature for 5 minutes.
[0146] 4) Centrifuge the reaction tube briefly and place it on a magnetic rack to adsorb the magnetic beads for 2 minutes. Wait until the solution is clear and carefully discard all the supernatant with a pipette.
[0147] 5) Add 150 μl of 80% ethanol (do not disperse the magnetic beads), use the magnetic rack to repeatedly adsorb the magnetic beads on two different sides to fully suspend the magnetic beads for washing, and carefully aspirate and discard all the supernatant with a pipette.
[0148] 6) Let stand at room temperature until the ethanol is completely evaporated, add 30 μl of nuclease-free water, and mix thoroughly.
[0149] 7) Centrifuge the reaction tube briefly and place it on a magnetic rack to adsorb the magnetic beads for 2 minutes until the solution is clear. Pipette the supernatant into a 1.5 ml centrifuge tube labeled with the library name.
[0150] 7. Library Quantification
[0151] The library was quantified using Qubit 3.0 and the concentration of the library was diluted to 5-10 ng / μl. The quantified library was sequenced on the machine, and the excess library was stored in a -20℃ refrigerator for long-term storage.
[0152] 8. Library on the computer
[0153] Each library was sequenced on the Illumina platform, and the single-end sequencing read length was no less than 150 bp.
[0154] 9. Data Analysis
[0155] The off-machine sequencing data is subjected to STR allele typing according to the analysis process of the present invention, the relative value of each STR sequencing depth is counted and the STR continuous interval is verified, and a chart is drawn.
[0156] 1. STR allele typing process
[0157] Use MISA software to process the data, including the following steps:
[0158] 1) Extract reads according to the upstream and downstream specific primers of the STR loci in Table 2.
[0159] Table 2 STR site-specific primer sequences
[0160]
[0161]
[0162] 2) Based on the quality of reads, reads with a Q-score higher than 20 and a base ratio lower than 80% were removed.
[0163] 3) Convert fastq to fasta sequence.
[0164] 4) Run MISA to identify simple sequence repeats (SSRs). The identified SSRs are required to have 2, 3, 4 and 5 base sequences repeated more than 4 times, and the maximum distance between two SSRs should not exceed 50 bases.
[0165] 5) For each STR locus of each sample, calculate the proportion of typing results of each repeat number to the total depth of the locus, remove SSR typing results with a proportion of less than 10%, and give the final typing.
[0166] The STR allele typing process is used to identify each STR as a heterozygous, homozygous, tri-allelic heterozygous gene or other typing status, and to calculate the proportion of the sequencing depth of different alleles to the total depth of the site.
[0167] 2. Statistical analysis of the relative value of each STR sequencing depth
[0168] The calculation process is as follows:
[0169] 1. Calculate the depth ratio of the test site of a single sample:
[0170] 2. Calculate the mean of the internal reference sites for a single sample:
[0171] 3. Calculate the mean of the depth ratio of the tested sites of negative samples:
[0172] 4. Calculate the mean of the internal reference sites of negative samples:
[0173] 5. Calculate the relative depth difference between the test sample and the negative sample (The theoretical value of Relative ration is 1, which is the dotted line position in the chart).
[0174] 6. Calculate STR based on the number of loci i Average: STR i The sum is divided by the number of sites n.
[0175] The relative value statistics of STR sequencing depth are used to verify the continuous interval of STR in samples.
[0176] 3. Verify STR continuous interval
[0177] The relative sequencing depth differences of STRs were divided into segments using the ring binary segmentation algorithm (CBS). The significance of the difference between the groups (p<0.05) was determined by randomly permuting the data within the divided fragments 1000 times, and the fragments were further divided to determine the fragment intervals with significant differences in sequencing depth (p<0.01). The intervals with different sequencing depths were corrected in combination with the STR typing results, and the multiples of the STR typing with the most occurrences in each interval were counted. If the multiples of STR typing between the intervals with different depths were inconsistent, the depth differences of the intervals were compared after the expansion boundary. If there was a significant difference in depth between the expansion and the expansion (p<0.05), the depth differences of the intervals were compared after the reverse reduction boundary. If there was a significant difference in depth between the reduction and the reduction (p<0.05), the breakpoints were not corrected, otherwise the corrected intervals were accepted to give the final STR continuous interval.
[0178] 4. Data Analysis
[0179] Based on the STR typing results, STR sequencing depth relative value and STR continuous interval obtained in the above process, the following analysis was performed.
[0180] When the relative sequencing depth difference of STR continuous intervals (STR i ) is close to 1 (threshold range 0.7~1.4), the chromosome sequence copy number of this interval is 2, indicating that there is no deletion or duplication in this continuous STR interval; if the STR typing results in this continuous interval show that there are no 3 or more STRs of one type (homozygous alleles, gene frequency is about 1), then ROH is excluded from this area; if the STR typing results in this continuous interval show that there are 3 or more STRs of one type (homozygous alleles, gene frequency is about 1), then it is highly suspected that ROH exists in this STR homozygous gene range. (such as Figure 3 F0000S STR test results and Figure 4 F0001S STR test results shown)
[0181] When the relative sequencing depth difference of STR continuous intervals (STR i ) is less than or equal to 0.7 or is 0, then the chromosome sequence copy number in this interval is 1 or 0, indicating that there is a deletion in this STR continuous interval, and the STR typing results in this continuous interval are all STR one typing (allele homozygous, gene frequency is about 1) or STR no data (gene frequency is about 0). (such as Figure 1 F0002S STR test results)
[0182] When the average value of the relative sequencing depth difference of the STR continuous interval is greater than or equal to 1.4, the chromosome sequence copy number of the interval is 3 or an integer greater than 3, indicating that the STR continuous interval is repeated. When the STR typing results in the continuous interval show three typings (three alleles heterozygous, gene frequency is about 1:1:1), or two STR typings (allele heterozygous, gene frequency is about 1:2), or one STR typing (allele homozygous, gene frequency is about 1), the chromosome sequence copy number of the interval is 3.
[0183] The test results of embryo samples F0002S and F0004S, and amniotic fluid sample F0000S are as follows. The STR results are arranged in order of position on chromosome 6:
[0184] Table 3 STR typing results of test samples
[0185]
[0186]
[0187] The right three columns of Table 3: the number of repetitions of the repeating unit of the STR locus, and ' / ' is used to distinguish alleles.
[0188] F0002S STR test results are as follows Figure 1 The F0004S STR test results are shown in Figure 2 The F0000S STR test results are shown in Figure 3 shown.
[0189] From the results of STR typing of the samples in Table 3, it can be seen that the STR typing of embryo sample F0002S is the same in the continuous intervals of D6S474 and D6S1277, that is, the gene is homozygous. Figure 1According to the F0002S STR test results, the average difference in relative sequencing depth in the continuous intervals of D6S477 and D6S1043 of the embryo sample F0002S was 0.9, indicating that the chromosome sequence copy number in this interval was 2, and the average difference in relative sequencing depth in the continuous intervals of D6S474 and D6S1277 was 0.6, indicating that the chromosome sequence copy number in this interval was 1 and there was a large chromosome deletion.
[0190] Combination Figure 2 According to the STR test results of F0004S and the STR typing results of the test samples in Table 3, the embryo sample F0004S has multiple STR loci with three types between D6S477 and D6S1277, that is, three alleles are heterozygous, and the gene frequency is about 1:1:1. Some STR loci have two types, that is, alleles are heterozygous, and the gene frequency is about 1:2; the average value of the relative sequencing depth difference in the continuous interval of D6S477 and D6S1277 is 1.4, indicating that the chromosome sequence copy number in this interval is 3 and there are large chromosome fragment duplications.
[0191] From the results of STR typing of the samples in Table 3, the STR typing of the amniotic fluid sample F0000S in the continuous interval of STR_1278631 and STR_1283352 is the same, that is, the gene is homozygous; Figure 3 According to the F0000S STR test results, the average relative sequencing depth difference of F0000S in the continuous interval of D6S477 and D3S2454 in the amniotic fluid sample is 1.0, indicating that the chromosome sequence copy number in this interval is 2, and there is no deletion of chromosome 6. The above results show that the sample has a homozygous region ROH of chromosome 6 in the continuous interval of STR_1278631 and STR_1283352.
[0192] The test results of family sample F0001 are as follows:
[0193] Table 4 STR typing results of family samples
[0194]
[0195]
[0196] 10. Uniparental disomy and its origin
[0197] It is known that the chromosomes of the father F0001F and the mother F0001M of the F0001 family are normal. From the STR typing results of the family samples in Table 4, the STR typing of the embryo sample F0001S is the same in the continuous intervals of D6S477 and D6S1277, that is, the gene is homozygous and consistent with one of the alleles of F0001F; Figure 4According to the F0001S STR test results, the average relative sequencing depth difference of embryo sample F0001S in the continuous interval of D6S477 and D3S2454 is 1.0, indicating that the chromosome sequence copy number in this interval is 2, and there is no deletion of chromosome 6. The above results show that the sample has a homozygous region ROH of chromosome 6 in the continuous interval of D6S477 and D6S1277, and is paternal uniparental disomy of chromosome 6.
[0198] The test results of the above samples are in line with expectations and have good accuracy.
[0199] The above embodiments are only preferred implementation modes of the present invention. It should be pointed out that ordinary technicians in this technical field can make several improvements and equivalent substitutions without departing from the principles of the present invention. These technical solutions after improvements and equivalent substitutions to the claims of the present invention all fall within the protection scope of the present invention.
Claims
1. An STR combination or STR marker, comprising 31 STR loci on chromosome 6 and 1 kb upstream and 1 kb downstream of each locus, or fragments thereof, wherein the STR loci include: D6S477, D6S1279, D6S2439, D6S1960, D6S1053, D6S1275, D6S1052, D6S1043, D6S474, D6S10 40, D6S2409, D6S1009, D6S970, D6S971, D6G15833, D6S2436, D6S1277, STR_1278631, STR_1 279799, STR_1280227, STR_1280328, STR_1281116, STR_1281316, STR_1281395, STR_1281 508, STR_1281666, STR_1282563, STR_1282613, STR_1282956, STR_1283352, STR_1283624, Preferably, the STR combination further comprises one or more STR loci as internal references and 1 kb upstream and 1 kb downstream of each locus, or fragments thereof.
2. A reagent for detecting the STR combination described in any embodiment of the present invention in a sample, wherein the reagent is a primer molecule that hybridizes with the sequence of the STR combination, and the primer molecule can amplify the STR site, Preferably, the primers include an upstream primer and a downstream primer, and: the upstream primer includes a universal sequence at the 5' end and a specific sequence for the STR site at the 3' end, and the 5' end of the upstream primer is complementary to a partial sequence at the 3' end of the adapter primer F; and / or, the downstream primer includes a universal sequence at the 5' end and a specific sequence for the STR site at the 3' end, and the 5' end of the downstream primer is complementary to a partial sequence at the 3' end of the adapter primer R. More preferably, the specific sequence for the STR locus in the upstream primer comprises a sequence as shown in one or more or all of SEQ ID NOs: 6-36, and / or, the specific sequence for the STR locus in the downstream primer comprises a sequence as shown in one or more or all of SEQ ID NOs: 42-72.
3. The reagent according to claim 2, characterized in that The primers include (1) one or more or all of SEQ ID NOs: 78-108, and / or (2) one or more or all of SEQ ID NOs: 114-144.
4. The reagent according to claim 2 or 3, characterized in that The sample is from a mammal, and / or the sample is amniotic fluid, embryo or body fluid.
5. Use of the reagent according to any one of claims 2 to 4 in the preparation of a diagnostic kit for identifying ROH, identifying uniparental disomy variation, determining the parental origin of uniparental disomy, and performing prenatal screening or diagnosis. Preferably, the identifying of ROH, identifying of uniparental disomy variation, and determining the parental source of uniparental disomy are respectively identifying whether ROH exists on chromosome 6, identifying of uniparental disomy variation on chromosome 6, and determining the parental source of uniparental disomy on chromosome 6.
6. A method for identifying homozygous chromosome regions ROH, identifying uniparental disomy variation, and determining the parental origin of uniparental disomy, comprising the steps of: (1) detecting the sequence of the STR combination, wherein the STR combination is preferably as described in any embodiment of the present invention, (2) Based on the test results of the STR combination, determine the STR allele typing, the relative value of each STR sequencing depth, and verify the STR continuous interval, so as to identify whether the chromosome contains ROH. Optional (3) judging uniparental disomy or uniparental disomy parental origin according to STR allele typing of the pedigree sample and whether the chromosome contains ROH. The pedigree sample at least includes an offspring sample and at least one parent sample.
7. The method according to claim 6, characterized in that Step (1) comprises constructing a library comprising the STR combination and sequencing the library, Preferably, step (1) comprises the steps of: (1.1) extracting genomic DNA, and (1.2) performing PCR using primers capable of amplifying the STR combination to obtain a library containing the STR combination, More preferably, step (1) further comprises: (1.3) performing PCR on the library using a sequencing adapter primer to obtain a sequencing library comprising the STR combination.
8. The method according to claim 6 or 7, characterized in that In step (2), when the average value of the relative sequencing depth difference is 0.7 to 1.4, and the STR typing result in the continuous interval is: there are not 3 or more consecutive STRs of the same type, then the continuous interval excludes ROH; when the relative value of the STR sequencing depth is 0.7 to 1.4, and the STR typing result in the continuous interval is: there are 3 or more consecutive STRs of the same type, then ROH exists in the STR homozygous gene range.
9. The method according to claim 6 or 7, characterized in that In step (3), the parental origins of the offspring uniparental disomy and uniparental disomy are determined based on the STR typing results. Preferably, when the STR typing in the continuous interval is all of the same type, and the average value of the relative sequencing depth difference in the continuous interval is 0.7 to 1.4, the continuous interval is uniparental disomy. When the STR typing in the continuous interval is the same as that of a parent, the uniparental disomy originates from the parent.
10. A device for identifying homozygous regions of chromosomes (ROH), identifying uniparental disomy variations, and determining the parental origins of uniparental disomy, the device comprising a memory, a processor, and a computer program stored in the memory and executable on the processor, characterized in that: When the processor executes the program, the following steps are implemented: (1) obtaining the sequence of the STR combination in the sample of the subject, wherein the STR combination is preferably as described in any embodiment of the present invention, (2) Based on the test results of the STR combination, determine the STR allele typing, the relative value of each STR sequencing depth, and verify the STR continuous interval, so as to identify whether the chromosome contains ROH. Optional (3) judging uniparental disomy or uniparental disomy parental origin according to STR allele typing of the pedigree sample and whether the chromosome contains ROH. The pedigree sample at least includes an offspring sample and at least one parent sample.
